<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03546933</url>
  </required_header>
  <id_info>
    <org_study_id>CIP 003 (US)</org_study_id>
    <nct_id>NCT03546933</nct_id>
  </id_info>
  <brief_title>VitalScan MCG Rule-out Multi-centre Pivotal Study - US</brief_title>
  <acronym>MAGNET ACS</acronym>
  <official_title>A Prospective Multi-centre Observational Study to Validate the Diagnostic Accuracy of a Transportable Magnetocardiograph Device for Acute Coronary Syndrome (ACS), Focusing on Rule-out Capability, in Patients Who Present to the Emergency Department With Chest Pain Symptoms Consistent With ACS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Creavo Medical Technologies Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Creavo Medical Technologies Ltd</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective multi-centre observational study to validate the diagnostic accuracy of a
      transportable magnetocardiograph device for acute coronary syndrome (ACS), focusing on
      rule-out capability, in patients who present to the emergency department with chest pain
      symptoms consistent with ACS.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    A correction needs to be made to the device's algorithm.
  </why_stopped>
  <start_date type="Actual">July 17, 2018</start_date>
  <completion_date type="Actual">August 6, 2019</completion_date>
  <primary_completion_date type="Actual">August 6, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity and specificity of MCG</measure>
    <time_frame>up to 3 month follow-up</time_frame>
    <description>Sensitivity and specificity for diagnosing ACS, focusing on rule-out, in chest pain patients with normal sinus rhythm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of adverse events and types</measure>
    <time_frame>up to 3 month follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortatility (divided into CV and non-CV causes) proportion</measure>
    <time_frame>through 1 week, 3 month follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3.Change in sensitivity and specificity for diagnosing ACS, focusing on rule-out, in chest pain patients with normal sinus rhythm, according to low, intermediate and high PTP groups</measure>
    <time_frame>up to 3 months follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACE post-presentation to the ED (rule-out of ACS divided into MCG vs reference standard (adjudicated ACS/non-ACS diagnoses))</measure>
    <time_frame>through 1 week, 3 month follow-up</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">651</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <arm_group>
    <arm_group_label>Chest pain patients presenting to the ED</arm_group_label>
    <description>All patients that present to the emergency department with chest pain and potentially other symptoms consistent with ACS and meet all eligibility criteria will undergo VitalScan Magnetocardiograph.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VitalScan Magnetocardiograph</intervention_name>
    <description>A passive, non-contact, mobile medical device that measures, displays, stores, and retrieves magnetic fluctuations caused by heart activity at a patient's bedside.</description>
    <arm_group_label>Chest pain patients presenting to the ED</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients that present to the ED with chest pain syndrome of suspected cardiac origin
        (i.e. symptoms consistent with ACS) who are in normal sinus rhythm
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient presents to the ED with chest pain syndrome of suspected cardiac origin (i.e.
             symptoms consistent with ACS)

          -  18+ year old male or female

          -  Patient is willing and able to give written informed consent

        Exclusion Criteria:

          -  ST-segment Elevation MI (STEMI)

          -  Clear non-ischemic cause for symptoms (e.g. trauma)

          -  Hemodynamic instability on admission (e.g. BP&gt;220mmHg systolic &amp; &gt;110mmHg diastolic,
             &lt;80mmHg systolic &amp; &lt;40mmHg diastolic, HR&gt;160bpm)

          -  Ventricular tachycardia or fibrillation that cannot be treated effectively

          -  Atrial fibrillation

          -  Thoracic metal implants

          -  Pacemaker or internal defibrillator

          -  Pregnancy (if after 20-week period)* or lactation

          -  Patient unable to lie down (i.e. supine position) or stay still on the examination bed

          -  Patient unable to understand the informed consent process and/or has a poor
             understanding of English (e.g. English- speaking relative/translator not available)

          -  Patient unable to comply with the requirements of the protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gregory J Fermann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cincinnati</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IU Health Methodist Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267-0769</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>May 9, 2018</study_first_submitted>
  <study_first_submitted_qc>June 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2018</study_first_posted>
  <last_update_submitted>September 17, 2019</last_update_submitted>
  <last_update_submitted_qc>September 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

